Doxorubicin multiple-dose vials
Rodondi, K.M.
American Journal of Hospital Pharmacy 47(9): 1976-1977
1990
ISSN/ISBN: 0002-9289 PMID: 2220843 Document Number: 366208
Document emailed within 1 workday
Related Documents
Olson, O.T.; Aslund, B.; Sandell, E. 1978: Studies on in-use microbial contamination of multiple-dose vials Acta Pharmaceutica Suecica 15(6): 401-405Wheeler, R.H.; Ensminger, W.D.; Thrall, J.H.; Anderson, J.L. 1982: High-dose doxorubicin: an exploration of the dose-response curve in human neoplasia Cancer Treatment Reports 66(3): 493-498
Manchikanti, L.; Falco, F.J.E.; Benyamin, R.M.; Caraway, D.L.; Helm Ii, S.; Wargo, B.W.; Hansen, H.; Parr, A.T.; Singh, V.; Hirsch, J.A. 2012: Assessment of infection control practices for interventional techniques: a best evidence synthesis of safe injection practices and use of single-dose medication vials Pain Physician 15(5): E573-E614
Barker, G.H.; Wiltshaw, E. 1981: Randomised trial comparing low-dose cisplatin and chlorambucil with low-dose cisplatin, chlorambucil, and doxorubicin in advanced ovarian carcinoma Lancet 1(8223): 747-750
Specenier, P.; Thomas, J. 1986: Weekly low-dose doxorubicin in advanced breast cancer Cancer Treatment Reports 70(6): 815
Logan, D.M.; Perrault, D.J.; McDermot, R.S. 1987: Acute laryngeal edema after single-dose irradiation and doxorubicin Cancer Treatment Reports 71(12): 1322
Cividalli, A.; Danesi, D.T.; Altavista, P.; Bonanni, M.; Persiani, D.; Segre, L.; Cruciani, G. 1995: 4'-Epi-doxorubicin and hyperthermia in a murine mammary carcinoma: influence of the dose and fractionation Anticancer Research 15(3): 739-743
Tateishi, T.; Kobayashi, S.; Shigeyama, C.; Nakamura, T.; Kobayashi, H. 1998: Pharmacokinetics of KW-4679 in the elderly: single-dose and multiple-dose trials Drugs under Experimental and Clinical Research 24(1): 1-7
Ilic, N.; Petricevic, A.; Kotarac, S.; Perisic, R. 1997: Single-dose ceftriaxone versus multiple-dose cefuroxime for antimicrobial chemoprophylaxis in pleuropulmonary surgery Panminerva Medica 39(3): 240-243
Murata, K.; Shiraki, K.; Kawakita, T.; Yamamoto, N.; Okano, H.; Nakamura, M.; Sakai, T.; Deguchi, M.; Ohmori, S.; Nakano, T. 2003: Low-dose chemotherapy of cisplatin and 5-fluorouracil or doxorubicin via implanted fusion port for unresectable hepatocellular carcinoma Anticancer Research 23(2c): 1719-1722
Burtness, B.; Windsor, S.; Holston, B.; DiStasio, S.; Staugaard-Hahn, C.; Abrantes, J.; Kneuper-Hall, R.; Farber, L.; Orell, J.; Bober-Sorcinelli, K.; Haffty, B.G.; Reiss, M. 1999: Adjuvant sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide (ATC) for high-risk breast cancer is feasible in the community setting Cancer Journal From Scientific American 5(4): 224-229
Giuliani, F.C.; Kaplan, N.O. 1980: New doxorubicin analogs active against doxorubicin-resistant colon tumor xenografts in the nude mouse Cancer Research 40(12): 4682-4687
Rahman, Z.; Champlin, R.; Rondon, G.; Frye, D.; Valero, V.; Mehra, R.; Hortobagyi, G. 1997: Phase I/Ii study of dose-intense doxorubicin/paclitaxel/cyclophosphamide with peripheral blood progenitor cells and cytokine support in patients with metastatic breast cancer Seminars in Oncology 24(5 Suppl 17: S17
Colpaert, F.C.; Janssen, P.A. 1982: Factors regulating drug cue sensitivity: the effects of dose ratio and absolute dose level in the case of fentanyl dose-dose discrimination Archives Internationales de Pharmacodynamie et de Therapie 258(2): 283-299
Mortimer, P.P. 1999: Away with multi-use vials! Aids 13(13): 1779-1781
Nogrady, M.B.; Eade, N. 1978: Mislabelled vials Journal of the Canadian Association of Radiologists 29(1): 5-6
Svedmyr, A. 1971: Dangerous multiple dose injection Lakartidningen 68(19): 2222
Dubach, U.C.; Korn, A.; Raaflaub, J. 1975: On the multiple-dose kinetics of glibornuride in man Arzneimittel-Forschung 25(12): 1967-1969
2001: Report: insulin vials have changed Revista de Enfermeria 24(3): 169
Steinijans, V.W.; Sauter, R.; Jonkman, J.H.; Schulz, H.U.; Stricker, H.; Blume, H. 1989: Bioequivalence studies: single vs multiple dose International Journal of Clinical Pharmacology Therapy and Toxicology 27(5): 261-266